Modal

Please choose your region

Content differs due to regional regulations.
You can switch regions at any time.

CLARITY Program continue reading →

Home
DeltaScan
Knowledge Base
About Us
- About us
- Supervisory Board
- Investors
- Jobs
- Contact
News
🇺🇸 US
- 🌐 Switch to international

Home
DeltaScan
Knowledge Base
About Us
- About us
- Supervisory Board
- Investors
- Jobs
- Contact
News
🇺🇸 US
- 🌐 Switch to international

en-us

Contact Us

News

Topic

FDA

All Post
Press
Research
Webinars
FDA

Categories

Press
Research
Webinars
FDA

Popular Posts

Prolira Appoints Dominic Spadafore as Chief Executive Officer
Webinar Recordings: Improved Delirium Management in Cardiothoracic Patients
The Delphi Delirium Management Algorithms. A practical tool for clinicians.
FDA Clearance of the DeltaScan® Brain State Monitor
Webinar: Improved Delirium Management in Cardiothoracic Patients

FDA Clearance of the DeltaScan® Brain State Monitor

Press FDA

FDA Clearance of the DeltaScan® Brain State Monitor

UTRECHT, The Netherlands, March 15, 2023 – Prolira BV, a high-tech company committed to enabling...

2 minutes read

15 March 2023

Read More

pageversion: 1.0

Proud sponsor of

eras-cardiac-sponsor-delirium-1

Connect.

Follow us on:

Stay informed.

Find out first about important updates and announcements by signing up to our newsletter.

The DeltaScan® Brain State Monitor is the first FDA-cleared and EU MDR certified device for detecting acute encephalopathy (acute brain failure; also defined as an indicator for brain health), a condition affecting millions of hospitalized patients 60 and older. It provides a quick and objective measurement of acute brain failure often before symptoms appear enabling clinicians to provide immediate treatment to improve patient outcomes.

Languages / Countries

English - United States

US HQ

(248) 487-6114

info@prolira.com

418 N. Main Street, Suite 200, Royal Oak, MI 48067

Postal Address Europe HQ

Winthontlaan 30C, 3526 KV, Utrecht, The Netherlands

Europe HQ

+31 (0)85 060 1656

info@prolira.com

Padualaan 8, 3584 CH, Utrecht, The Netherlands

Copyright © 2024 Prolira All Rights Reserved

Prolira’s privacy statement | Cookie statement